This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Zhaobing Cheng: Innovator in Pharmaceutical Extraction Methods
Introduction
Zhaobing Cheng is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the extraction of mupirocin. His innovative methods have the potential to enhance industrial applications in the pharmaceutical industry.
Latest Patents
Zhaobing Cheng holds a patent for a method titled "Method for extracting mupirocin." This method involves several key steps, including resin adsorption, desorption and concentration, multi-step extraction, and dehydration and decoloration. The multi-step extraction process incorporates at least one ester solvent extraction and at least one alkaline water extraction. Remarkably, this method achieves an extraction recovery rate of 80% or more, with mupirocin purity also exceeding 80%.
Career Highlights
Zhaobing Cheng is associated with Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical extraction. His work is pivotal in advancing extraction techniques that can be industrialized, thereby improving the efficiency and effectiveness of mupirocin production.
Collaborations
Zhaobing Cheng collaborates with talented individuals in his field, including Yiming Xu and Kai Zhang. Their combined efforts contribute to the innovative environment at their company, fostering advancements in pharmaceutical technologies.
Conclusion
Zhaobing Cheng's contributions to the extraction of mupirocin exemplify the impact of innovative methods in the pharmaceutical industry. His work not only enhances extraction efficiency but also sets a standard for future developments in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile